BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17175355)

  • 1. Influence of hepatitis C on renal function after liver transplantation.
    Asfandiyar S; Abouljoud M; Kim D; Brown K; Yoshida A; Arenas J; Sherbondy M; Divine G; Moonka D
    Transplant Proc; 2006 Dec; 38(10):3643-5. PubMed ID: 17175355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renal failure on liver transplantation survival.
    Afonso RC; Hidalgo R; Zurstrassen MP; Fonseca LE; Pandullo FL; Rezende MB; Meira-Filho SP; Ferraz-Neto BH
    Transplant Proc; 2008 Apr; 40(3):808-10. PubMed ID: 18455024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
    Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM
    Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD; Lyden ER; Gulizia JM; McCashland TM
    Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent hepatitis C virus disease after liver transplantation and concurrent biliary tract complications: poor outcome.
    Katz LH; Mor E; Brown M; Bar-Nathan N; Shaharabani E; Sulkes J; Pappo O; Tur-Kaspa R; Ben-Ari Z
    Clin Transplant; 2006; 20(4):465-70. PubMed ID: 16842523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of combined liver and kidney transplantation in hepatitis C: a single-center long-term follow-up experience.
    del Pozo AC; Martín JD; Rodriguez-Laiz G; Sturdevant M; Iyer K; Schwartz M; Schiano T; Lerner S; Ames S; Bromberg J; Thung S; de Boccardo G
    Transplant Proc; 2009 Jun; 41(5):1713-6. PubMed ID: 19545713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent risk factors and natural history of renal dysfunction in liver transplant recipients.
    Pawarode A; Fine DM; Thuluvath PJ
    Liver Transpl; 2003 Jul; 9(7):741-7. PubMed ID: 12827563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation.
    Lafayette RA; Paré G; Schmid CH; King AJ; Rohrer RJ; Nasraway SA
    Clin Nephrol; 1997 Sep; 48(3):159-64. PubMed ID: 9342487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation: impact of pretransplant renal insufficiency.
    Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
    Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal failure and abdominal hypertension after liver transplantation: determination of critical intra-abdominal pressure.
    Biancofiore G; Bindi L; Romanelli AM; Bisà M; Boldrini A; Consani G; Danella A; Urbani L; Filipponi F; Mosca F
    Liver Transpl; 2002 Dec; 8(12):1175-81. PubMed ID: 12474158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?
    Smallwood GA; Devine R; Fasola C; Stieber AC; Heffron TG
    Transplantation; 2008 Dec; 86(12):1795-8. PubMed ID: 19104424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
    Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
    Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS; Burroughs AK; Burra P; Alberti AB; Samonakis D; Cammà C; De Carlis L; Minola E; Quaglia A; Zavaglia C; Vangeli M; Patch D; Dhillon A; Cillo U; Guido M; Fagiuoli S; Giacomoni A; Slim OA; Airoldi A; Boninsegna S; Davidson BR; Rolles K; Pinzello G
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elderly donors for HCV(+) versus non-HCV recipients: patient survival following liver transplantation.
    Boin IF; Ataide EC; Leonardi MI; Stucchi R; Sevá-Pereira T; Pereira IW; Cardoso AR; Caruy CA; Luzo A; Leonardi LS
    Transplant Proc; 2008 Apr; 40(3):792-6. PubMed ID: 18455019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of hepatitis C virus infection in renal transplant recipients.
    Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
    Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure after liver transplantation: incidence, etiology, therapy, and outcome.
    Junge G; Schewior LV; Kohler S; Neuhaus R; Langrehr JM; Tullius S; Kahl A; Frei U; Neuhaus P
    Transplant Proc; 2006 Apr; 38(3):723-4. PubMed ID: 16647455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
    Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
    Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.